Micheall O'Neill

Dr. O’Neill has more than 20 years’ experience working in the pharmaceutical industry. He was a Senior Research Scientist and Portfolio Manager at Eli Lilly for much of this time where he was responsible for developing project plans for the selection of projects and for their progression from discovery through to important development milestones. Dr. O’Neill established his own consulting business, Eolas, to help early stage companies to organize their research along commercial lines. Previously Dr. O’Neill was Head of Laboratory at Almirall and a Research Neuroscientist at Merck. Michael has authored over 80 papers, book chapters, patents and abstracts and is Honorary Visiting Senior Lecturer at the Science Policy Research Unit at the University of Sussex. Michael holds a BA Psychology from UCC and a PhD from QUB Belfast


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Inflection Biosciences

Inflection Biosciences Ltd is an early stage, drug development company with a focus on discovering and developing innovative small molecule therapeutics addressing major unmet needs in cancer.


Industries

Headquarters

Blackrock, Ireland

Employees

1-10

Links